MDWD vs TLRY
MediWound Ltd. and Tilray Brands, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | MDWD | TLRY |
|---|---|---|
| Revenue | $17.0M | $915.5M |
| Net income | $-23.9M | $-121.4M |
| Gross margin | 19.2% | 28.4% |
| Net margin | −140.8% | −11.5% |
| Return on equity | −63.9% | −7.8% |
| Diluted EPS | −$2.10 | −$1.09 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $-21.6M | · |
| Equity | · | $1.6B |
| Net debt / equity | · | −0.13× |
| Current ratio | 2.33× | 2.21× |
| Revenue CAGR 5y | −4.9% | 12.3% |
| Profit CAGR 5y | · | · |
TLRY bills 54.0× the revenue of MDWD, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | MDWD | TLRY |
|---|---|---|
| FY2025 | $17.0M | $915.5M |
| FY2024 | $20.2M | $821.3M |
| FY2023 | $18.7M | $788.9M |
| FY2022 | $26.5M | $627.1M |
| FY2021 | $23.8M | $628.4M |
| FY2020 | $21.8M | $513.1M |
| FY2019 | $31.8M | $405.3M |
| FY2018 | $3.4M | $179.3M |
| FY2017 | $2.5M | $20.5M |
| FY2016 | $1.6M | $12.6M |
Bottom line
| Fiscal year | MDWD | TLRY |
|---|---|---|
| FY2025 | $-23.9M | $-121.4M |
| FY2024 | $-30.2M | $-2.2B |
| FY2023 | $-6.7M | $-245.0M |
| FY2022 | $-19.6M | $-1.5B |
| FY2021 | $-13.6M | $-476.8M |
| FY2020 | $-9.2M | $-367.4M |
| FY2019 | $5.0M | $-102.5M |
| FY2018 | $-1.1M | $-25.0M |
| FY2017 | $-22.1M | $-7.8M |
| FY2016 | $-18.9M | $-7.9M |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$898,495,000 | TLRY |
| FY2024 | −$801,087,000 | TLRY |
| FY2023 | −$770,256,000 | TLRY |
| FY2022 | −$600,628,000 | TLRY |
| FY2021 | −$604,609,000 | TLRY |
| FY2020 | −$491,322,000 | TLRY |
| FY2019 | −$373,537,000 | TLRY |
| FY2018 | −$175,902,000 | TLRY |
| FY2017 | −$18,042,000 | TLRY |
| FY2016 | −$11,086,000 | TLRY |
TLRY has reported the higher revenue in every one of these 10 fiscal years. The gap has widened since the earliest year compared.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −129.3 pp | TLRY |
| FY2024 | +116.1 pp | MDWD |
| FY2023 | −7.8 pp | TLRY |
| FY2022 | +156.1 pp | MDWD |
| FY2021 | +12.1 pp | MDWD |
| FY2020 | +23.2 pp | MDWD |
| FY2019 | +40.5 pp | MDWD |
| FY2018 | −10.9 pp | TLRY |
| FY2017 | −849.4 pp | TLRY |
| FY2016 | −1149.8 pp | TLRY |
The higher net margin has changed hands between MDWD and TLRY over this period.
10 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
MDWD's net margin has been more volatile than TLRY's over the 10 comparable fiscal years — 403.5 percentage points of standard deviation against 85.6.
10 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MDWD and TLRY over these 10 fiscal years — MDWD led in 5 and TLRY in 5.
10 of 10 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TLRY's return on equity has been more volatile than MDWD's over the 6 comparable fiscal years — 110.2 percentage points of standard deviation against 52.5.
6 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between MDWD and TLRY over these 6 fiscal years — MDWD led in 2 and TLRY in 4.
6 of 11 comparable fiscal years — a year missing data on either side is not counted.